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The representations of the mutations and the nature of spontaneous mutation process and mutagenesis induced
by exogenous oncoviruses, DNAs and proteins-mitogens are analysed. Exogenous biological factors induce DNA
damages in regulatory-informational way, acting on the cellular systems for maintenance of genetical stability.
Molecular mechanisms are the same as at spontaneous mutagenesis but they are realized with the participation
of alien genetical material. Among biological mutagens, the oncoviruses and mobile genetic elements (MGEs)
are distinguished as the strongest destabilizing factors which direct tumor transformation of somatic mamma-
lian cells. Genetical reprogramming or changing the programs of gene expression at the differentiation of stem
and progenitor cells under growth factors and citokines is probably followed by mutations and recombinations
as well.
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Introduction. Problems of mutagenesis move to the fo-
refront of science and society development in connec-
tion with anthropogenic pollution of the environment
and accumulation of mutations in genomes of human
and other organisms. According to one of the forecasts
there are increasing frequency of hereditary and soma-
tic diseases, reduction in longevity and other adverse ef-
fects. According to other forecasts there is a process of
accelerated evolution which leads to the emergence of
new forms of life. The achievements of modern science
will promote new technologies which might be applied
for reorganization of own genome into the hands of the
mankind.
Each time after discovering mutagenic action of
physical, chemical or biological mutagens there was ob-
served long «lag period» when no proper attention was
paid to these investigations. However, starting from the
middle of the 1970s there was observed avalanche-like
accumulation of the number of works devoted to the
genetic consequences of mutagens action in the human
habitat, especially «supermutagens» [1, 2]. It resulted
in forming certain ideas about mutations and mecha-
nisms of realization of the mutagen impacts on cell sys-
tems, prospects and directions of further researches.
Some actual questions of mutagenesis, both sponta-
neous and induced by various factors, were discussed
at a thematic seminar «Fundamental problems of muta-
genesis» in the IMBGNASU as well as on the pages of
special issue of the journal «Biopolym. Cell» in 2007.
New data, allowing the development of ideas about
spontaneous and induced mutagenesis appeared since
that time.
This review is devoted to some questions of sponta-
neous mutagenic process and to the detailed conside-
ration of features and mechanisms of mutagenesis, in-
duced by biogenic factors, in the populations of the eu-
karyotic cells because the literature data on induced mu-
tagesis are insufficient and inexact. The researches on
viruses, viral vaccines and exogenous DNAs gave the
basic material for development of comprehension on
biological mutagenesis in eukaryotic cell systems in vi-
vo and in vitro [3–7]. Hesin [8] for the first time genera-
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lized the data on the existence of cell mechanisms,
which control the mutational variability and can cause
sharp destabilization of a genome or «mutational explo-
sions» under stressful conditions, and thus marked a
special role of oncoviruses and mobile genetic elements
(MGEs) in this phenomenon.
We use the term «biological mutagenesis» in a broad
sense, meaning various genetical changes caused by bio-
genic factors while some authors under this term imply
insertion–deletion mutagenesis only [9].
Mutations and spontaneous mutagenic process.
Ability to change the genetic material or to mutate is a
universal property of living forms from viruses and mic-
roorganisms to the highest plants, animals and human
beings. The term «mutation» was offered by Gugo de
Frieze at the beginning of the last century in his classi-
cal work «Mutation theory», the substantive provisions
of which still have not lost their value. Since that time,
mutations imply discrete, stable changes of a hereditary
material manifested in the phenotype. The process of
mutations emergence is named mutagenic or mutage-
nesis although the latter term is more often used in re-
gard to the mutations induced by mutagens [2]. At the
present stage of genetics development the most general-
ly accepted is a short definition of mutations – «muta-
tional variability is inherited changes of genetic mate-
rial» [10, 11] although the essence of the changes hap-
pening at submolecular levels of the DNA organization
thus is not disclosed.
Arising genetic changes can affect only sequences
of nucleotides in DNA (gene or point mutations), to re-
sult in reorganizations within chromosomes (chromo-
somal aberrations), and to induce increasing or reducing
number of separate chromosomes (aneuploidy) or the
whole sets of chromosomes (genomic mutations) [1, 2,
10, 11]. Detection of «strange» properties of the muta-
tions induced by exogenous DNAs and viruses (locus
specificity, instability, domination of minideletions),
maybe, for the first time seriously affected the initial
ideas about stability of the acquired genetic changes [3,
12, 13].
In the last decades it was created the concept about
the macromutations manifested by large structural reor-
ganizations of genomes in the course of their evolution,
such as: a) insertions and deletions of nucleotide sequ-
ences during integration ofMGEs, oncoviruses, exoge-
nous DNAs; b) reorganizations which change the num-
ber of chromosomal sets, appearance and elimination
of separate chromosomes, 3) diminution of chromatin
(elimination of genetic material when forming somatic
cells from the germinal cell line of some organisms). In
the majority of organisms the isolation of genetic mate-
rial is reached by means of supercompact piling of chro-
mosomes [10, 14]. A new point in the understanding of
the nature of mutations is a consideration that the epi-
genetic changes caused by DNA methylation are the
manifestation of «epigenetic mutagenesis»; which fol-
lowed by induction of DNA damages [15, 16].
Macromutations are probably the most powerful
factors of genome destabilization and at the same time a
source of its accelerated evolution. As an example can
be an extraordinary high rate of evolution of an Asian
forest mouse, the karyotype of which consists of 23
pairs of autosomes, a pair of sexual and 9 additional B-
chromosomes which serve as genetic material for reor-
ganizations [17]. The DNA excess and nucleotide sequ-
ences of various degree of repeatability in heterochro-
matin regions of chromosomes of different species play
a special role in these processes [9, 10, 14–18].
Spontaneous mutagenesis, i. e. the emergence of
mutations at the lack of intended treatment by muta-
gens, represents a final result of total influence of va-
rious factors on the processes of replication, reparation,
recombination, modifications and restriction in the cour-
se of normal cellular metabolism [1, 2, 10]. It is conside-
red that endogenous factors comparing to exogenous
ones make bigger input into spontaneous mutagenesis,
and DNA replication is one of the chief «suppliers» of
mistakes [1, 2, 10].
Mutations are the source of genetic variety as a ne-
cessary condition for the development and adaptation
of organisms; probably therefore the relatively perma-
nent rate of a spontaneous mutagenesis, characteristic
of given species or cell types was evolutionarily fixed
[1, 2, 19, 20]. As a rule, the frequency of spontaneous
mutations in the highest eukaryotes is characterized by
low value of 10
–5–10–8 per a gene per one generation.
And the parameter reverse to the frequency of sponta-
neous mutations reflects the level of genetic stability of
the biological systems and is hereditary fixed sign [21].
However, fluctuations of the frequency of spontaneous
mutations for various cellular populations of an orga-
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nism can differ by thousands times [1, 2]. There is an
amazing example of self-regulated mutagenesis of hu-
man organism: during all life high mutational rate is
maintained in the populations of the antibody produ-
cing cells but such genetic instability is strictly limited
to the certain hypervariable sites of the corresponding
immunoglobulin genes [22].
Apparently, a certain level of genetic stability and
variability of different DNA locuses is encoded in the
structure of a genome and depends on a coordinative
work of the numerous mutators and anti-mutators ge-
nes, regulatory genetic elements responsible for the cour-
se of the main matrix processes [23, 24]. There is a ques-
tion who is a «managing director» of all this machi-
nery? Whether it operates at higher levels of the orga-
nization above cell populations or maybe the regulation
of mutagenesis is determined by the internal self-func-
tioning of cell genome?
In a post-genomic era with the appearance of new
opportunities for studying the principles of genomes or-
ganization and function it became obvious that the fea-
tures of primary DNA structure, existence of standard
epigenetic marking of genes by methylating, functional
activity of a cell, fidelity of matrix processes and many
other factors influence spontaneous mutagenesis [25].
Just illustrating one of the important points, «there is an
opinion according to which violations in the standard
of epigenetic marking of genes in stem and progenitor
cells can be the reason of emergence of a cancer that is
accompanied by DNA damages» [15].
We succeeded to get some data in favor of this hypo-
thesis analysing the rearrangements of chromosomes
while isolating stem cells from mammalian organism
and cultivating themwith adaption to new conditions in
vitro [26–28]. The human and mouse cells were passed
hundreds of generations in culture, and now they might
be considered as spontaneously immortalized cell lines
[26, 27]. It should be noted that the cells grew up as a
standard monolayer culture and were not treated by any
mutagenic compound.
As it was shown earlier by other authors earlier, we
also revealed two stages in the forming of established
cells lines: the first stage is characterized by structural
instability, and the second one by stabilization of the ka-
ryotype. The comparative cytogenetic analysis of human
and mouse stem cells at different passages of cultiva-
tion showed that the karyotype of the former was more
stable [28, 29]. However, many various chromosomal
aberrations (translocations, deletions, insertions) and
changes of chromosome numbers in populations of hu-
man cells have been revealed [30].
However, in both human andmouse cells, we found
one general tendency: increasing level of MGMT gene
expression in the period of structural instability, and then
gradual decreasing in its expression, during the stabili-
zation stage. After long cultivation of the human cell line
4BL it was impossible to reveal either mRNA, orMGMT
protein in its regular form (24 kDà) although there was
constantly present a protein with a larger molecular
weight (50 kDà) which was recognized by specific mo-
noclonal antibodies [30–32]. A decrease in a level of the
expression of MGMT might be caused by methylation
of the corresponding promotor and/or body of this gene.
By the comparative genome hybridization method
the deletion of the area of 10 chromosomewhereMGMT
gene is localized, and even more, the complete loss of
one from two chromosomes 10 was revealed in the part
of cell population [29]. The total absence of repair en-
zyme MGMT caused extremely high sensitivity of the
human cells 4BL to the action of alkylating agent
nitrosoguanidine (unpublished results). In the absence
of chemical treatment the human cells preserved the
viability, capacity to proliferation and differentiation.
Thus, the literature and our own data testify that du-
ring the formation of cell lines in vitro the genetic variabi-
lity with evolution of karyotype is a result of spontane-
ous mutagenesis, and this process is followed by repres-
sion of the DNA repair systems [33]. These data are one
more argument in favor of the idea about accelerated
evolution of eukaryotic genomes under stressful envi-
ronmental conditions. They also indicate that similar
reorganization of cell genome under the influence of
stress factors might be realized in the cells in vivo.
The question is whether it is possible to regulate the
mutation process externally by means of natural nucleo-
tide sequences (oncoviruses,MGEs) or by theDNA-con-
structions created by genetic engineering or by separate
proteins (hormones, growth factors, cytokines) in eu-
karyotic cell systems.
Mutagenesis induced by exogenous biological
factors. In everyday life we constantly face chemical
and biological mutagens; often they act as a complex.
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However, it is difficult to agree with the classification
of mutagens where for the first time biological factors
were included in the category of chemical mutagens,
and nothing was said about specifics of their mutagenic
action [2]. Such state of things served as one more ar-
gument to consider this question.
It is the International agency on research of cancero-
genic risk in the World Health Organization (WHO),
which concluded that food is a source of a complexmix of
mutagens and carcinogens of different nature [34]. An
application of genetically modified food and recombinant
DNAs on the basis of virus vectors and human cells as
pharmaceutical preparations for gene and cell therapy,
poses a problem of genetic consequences of alien biolo-
gical factors introduced into a human body [35–37].
To the biological factors, influencing mutational
process towards both its increase and fall, belong viru-
ses, nucleic acids, MGEs, various cellular metabolites,
hormones, enzymes, vitamins, etc. [38]. As it has been
already noted,MGEs and oncoviruses are especially dis-
tinguished as mutagenic factors which are capable not
only of destabilizing but also of carrying out full repro-
gramming of the cell genome on the way to malignant
transformation [8, 14–16].
The data obtained by researchers of several labora-
tories using încoviruses of different groups, convin-
cingly showed that an induction of gene mutations un-
der the influence of these factors in somatic mamma-
lian cells in vitro [39–44] and in vivo [45–47] is a uni-
versal phenomenon. Essential differences in the muta-
genic effects which were produced by exogenous viru-
ses or DNAs in experiments with Drosophila melano-
gaster [3, 12, 13, 48] were found. As a rule, in mamma-
lian cells the increasing of general mutagenesis was
observed, i. e. mutations were revealed in all genes
which researchers investigated. The types of mutations
were others: mainly, breaks of chromosomes and repla-
cement of bases that pointed to a possible role of DNA
replication and reparation in the observed mutagenic
effect. Insertions of the exogenous nucleotide sequen-
ces into the mutants by DNA-genome viruses, were not
found at all [4, 6, 7, 44]. In the case of retroviruses they
did not exceed 4% [41, 42], and in transgenic animals –
8 % [45–47].
A basic point of our further investigations on map-
ping mutagenic activity was the assumption that the
transforming area of oncogenic adenovirus which sti-
mulates cell DNA replication and causes malignant
transformation, is mutagenesis inducer as well. In the
article published in the J. Cell. Sci. in 1985, were pre-
sented our results which testified that oncogene or E1B
operon of adenovirus, responsible not only for mainte-
nance of malignant transformation but also for mutage-
nesis in somatic mammalian cells [49]. This work was
admitted as the first attempt of mutagenesis regulation
by means of a transforming gene [50].
We developed and approved a special methodical
approach: using restriction fragments of adenoviral ge-
nome, regulatory genetic elements, TPA tumor promo-
tor, nucleotide-threephosfates, by means of which it was
possible to modulate mutagenic effects [7]. The TPA
was tested in experiments with using carcinogens of dif-
ferent nature [51]. This approach allowed us to estab-
lish the effect of increasing mutations frequency with
all early operons (E1A, E1B and E4) of bovine adenovi-
rus type 3 (BAV3) and to show the dependence of muta-
genic effect on the level of viral oncogenes expression
[49, 51]. The maximal mutagenic effect (10–20-fold ex-
cess of mutation frequency in relation to control), compa-
rable to the action of chemical supermutagen nitrosogua-
nidine,was foundwith viral transformingE1 area (Fig. 1).
The system of early adenoviral operons allowed us
to demonstrate how oncogenic virus «manages» the tu-
mor transformation and mutagenesis in eukaryotic cell
system. It is known that transforming E1 area (operons
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Fig. 1. Induction of mutations and reprogramming the mammalian
cells to tumor transformation under the influence of transforming area
E1 (early operons E1A+ E1B) of oncogenic adenovirus BAV-3
E1A, E1B) interacts with many cellular genes, stimu-
lating the expression of cellular targets responsible for
DNA replication and cells proliferation, but the early
E4 area on the contrary suppresses accumulation of cel-
lular mRNA and thus prevents the development of in-
fectious process (Fig. 2). Similarly the E4 area acted in
our system: it blocked the manifestation of induced mu-
tagenesis at joint introduction with the transforming E1
area or E1B operon and thus prevented damage of cell
DNA [52, 53]. That is why the mutagenic effect of the
total oncovirus was much less comparing with the mu-
tagenic effect of its transforming E1 area only.
Our data on mutagen activity of the transforming
viral genes were coordinated with the results received
by other authors with fragments of genomes of diffe-
rent DNA-containing viruses: highly oncogenic human
adenovirus type 12 [54–56] and herpes simple virus ty-
pe 1 [57, 58]. The mutagenic properties of SV40 T-an-
tigen, encoded by early gene A, have been shown [59].
It was not excluded that mutagenesis, induced by on-
cogenes of cellular origin which were entered as a part
of recombinant plasmids [60–62], was also connected
with their proteins since no insertions of exogenous
DNA were found in mutants [62].
The data on the ability of viral or cellular oncopro-
teins to induce gene mutations allowed us to pass from
complicated model «exogenousDNA–cell» tomore sim-
plified model «exogenous protein–cell». We used a
number of the proteins, capable of revealing mutagenic
and cytotoxic activities and causing the programmed
death: àpoptosis. It has been shown that such different
proteins as human hormone insulin and cytokine EMAP
II and lectins of plant and animal origin induced gene
mutations in somatic mammalian cells at early terms
after their introduction [7, 63, 64]. Direct dependence
of the induced mutagenic effect on the concentration of
lectins in a wide range of doses was shown [63].
The investigated lectins of different origin at con-
centration of 0.2 g/ml modulated mutagenesis, indu-
ced by chemical mutagen ni.trosoguanidine, towards
its drop, acting in this case as antimutagens. It testifies
that proteins and nitrosoguanidine are able to compete
for the general cellular targets although they presumably
af- fect different cell mechanisms. It is known that
lectins reversibly interact with receptors of a
superficial cel- lular membrane and influence various
signal-regulato- ry ways. According to the literature
and our own data, the studied carbon-containing
proteins are capable to stimulate cell proliferation at
small concentration, whi- le at higher concentration (2
g/ml and above) on the con- trary – to induce cytotoxic
effect and apoptosis [65, 66].
The studied mutagenic effects were realized provi-
ding that the exogeneous factors actively interfere with
the systems for maintenance of genetic stability via me-
chanisms of nucleic–protein recognition [67]. So, if exo-
genous nucleotide sequences were not expressed in the
cell system due to the lack of special regulatory elements
or considerable damage of matrix properties, as a result
of alkylation, heating or UV-light, they did not show
the genetic activity as well [7, 43, 52, 53, 68]. It is pos-
sible to make some conclusions about possible mecha-
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Cell repressor, which is able to permit transcription of early viral operons
Cell targets for early area E4 inhibit accumulation of cell mRNAs
Cell targets for early operon E1B:
Protooncogenes, responsible for tumorforming ability
of mammalian cells (gene for protein p53)
Cell targets for early operon E1A:
Genes of proproinsuline, timidinekinase, topoisomerase 1,
Protooncogenes, responsible for immortalization
EIA
(6-9 polypeptides, 22-58 kDa)
EIB
(2 polypeptides, 19-21 kDa, 54-58 kDa)
E4
(6-16 polypeptides, 6-16 kDa)
Fig. 2. Interactions of early operons (E1A, E1B, E4) of oncogenic adenovirus BAV-3 between themselves and with cellular genes during repro-
gramming the mammalian cells to tumor transformation
nisms ofmutagenic action of exogenic biological factors.
S. M. Gershenzon emphasized that, unlike physical and
chemical mutagens, macromolecules cannot cause socal-
led adducts, in the structure of cell DNA [3, 12, 13]. It
seems to be the most probable explanation that exo-
genous DNAs which keep matrix properties have regu-
latory and information impact on cell DNA via the sys-
tems for maintenance of genetic stability and involve
the samemechanisms as at spontaneousmutagenesis but
with participation of alien genetic materials [69, 70].
Regulatory influence of exogenous biological fac-
tors on matrix processes. Both exogenous transfor-
ming DNAs and individual proteins under special con-
ditions were able to stimulate cell proliferation and in-
duce gene mutations in eukaryotic cell systems. How-
ever, at the external similarity of a phenomenon they
caused reprogramming cells diversely and, therefore,
influenced different signal-regulatory ways and mole-
cular mechanisms.
The assumptions concerning mechanisms of muta-
genic action of DNA-genome viruses consist in: 1) sti-
mulation of additional points of origin replication and
correspondingly more DNA breaks [71]; 2) amplifica-
tion of unstable sites of cell DNA (dynamic mutations)
[72, 73]; 3) reverse transcription and transposition of
MGEs [9, 71–74]; 4) decreasing in accuracy of DNA
biosynthesis [75].
Early adenoviral operons interact among themsel-
ves and activate many cellular targets responsible for
the stimulation of cell DNA replication (Fig. 2). The ear-
ly E1 area revealed the maximal mutagenic [7, 42, 43,
69, 70] and transforming activity [71, 76]. The function
of proteins of E1A operon consists, mainly, in immorta-
lization of primary mammalian cells, and the proteins
encoded by E1B operon are necessary for both induc-
tion, and maintenance of transformed state [76]. The
protein 58 kDa encoded by an E1B operon, directly con-
tacts protein ð53 which plays a key role in regulation of
a cellular cycle [56, 77]. The role of products of E4 ear-
ly operon in transformation is not clear, but it is known
that the protein, encoded by it, contacts protein 58 kDa
[78]. Thus, «managing» the viral operon via protein
ð53 is able to regulate cell switching on a way of
reparation or apoptosis [56, 79].
Concerning investigated lectins there are data on
their ability to induce apoptosis; and for some of them
(lectins from bark and inflorescences of Sambucus nig-
ra) one-thread breaks in individual mammalian cells
were directly detected by means of the DNA comet me-
thod [80]. In our recent work the induction of the cor-
responding apoptotic proteins under the influence of phy-
togemagglutinin and its isoforms has been shown (un-
published results). Besides, it is impossible to exclude
that mutagenic activity of some lectins is realized
through their specific enzymatic activity, such as N-
glycosidase which leads to formation of apurine gaps in
the cellular DNA. There are data about the lectins of
RIP group which are capable not only of causing apu-
rine gaps but also of inhibiting an excision repair pro-
cess [81, 82].
Inhibition of an excision reparation under the influ-
ence of oncoviruses was observed in all types of cell
systems, especially at joint action with chemical muta-
gens, for example, nitrosoguanidine [33, 83]. We assu-
med that the presence in the cells of a large number of
molecules of an exogenous DNAmatrix of different ori-
gin can distract considerable part of correcting and re-
pairing enzymes and thus promote formation of the in-
duced mutations in cell DNA. As it has been already
mentioned, the unique MGMT repair enzyme which
corrects one of themost dangerous damage, O
6-methyl-
guanine, induced by nitrosoguanidine [84, 85] was
studied in our research.
There was a considerable strengthening of mutage-
nic effect of nitrosoguanidine in the presence of virus
particles, native or alkylated DNAs, which are good sub-
strates for MGMT enzyme, in mammalian cells in vitro
[68]. When the molecules of modified base O6-benzyl-
guanine almost completely inhibited activity ofMGMT,
there was observed the maximal increasing frequency
of mutations in hprt locus induced by nitrosoguanidine
[86, 87].
The molecular analysis of the mutations, induced by
nitrosoguanidine at the active and suppressed reparative
activity, allowed detailed study on the features ofMGMT
enzyme activity. On the contrary to the enzymes of ex-
cision repair system, MGMT was equally effective in
removing methyl groups from both transcribed and non-
transcribed threads of DNA, and showed the increased
accuracy in the correction of damages in GC-rich areas
which have higher temperature of melting and save a
double-stranded structure for a longer time [86–88].
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As it is already specified, at joint action of lectins
and nitrosoguanidine the decreasing mutagenic effect
was observed. Lectins, unlike oncoviruses, stimulated
apoptosis in non-permissive cell systems. Besides, it was
shown that lectins and cytokine EMAP II strengthened
the expression of proteins whichwere recognized bymo-
noclonal anti-MGMT antibodies [30–32]. Thus, these
kinds of proteins might be used for strengthening repair
system which removes alkyl groups from cellular DNA.
Investigations of various MGMT inhibitors and activa-
tors have special value for further optimization of che-
motherapy by alkylating compounds [90, 91].
Regulatory influence of E1 transforming area of on-
cogenic adenovirus on replication and reparation can-
not explain its complete mutagenic effect. In mamma-
lian cells any exogenous transforming DNA including
viral one, undergoes quite long evolution [71, 92–98].
Researchers distinguished the following stages of gene-
tic transformation: 1) temporary expression; 2) creation
of the integrated structure (characterized by formation
of macromolecular complexes and structural instabi-
lity); 3) stable transformation; 4) involution of alien
nucleotide sequences when they are exposed to methy-
lation and eliminated. Sometimes in transformed cells
there were completely absent viral nucleotide sequen-
ces but changed cell phenotype remained [98].
When studying the dynamics of mutagenic action of
E1 transforming area we found two liftings of mutation
frequency: in early terms after transfection which cor-
responds to a stage of a temporary expression and inmo-
re remote terms corresponding to the period of structu-
ral instability (Fig. 1). The remote mutagenic effect was
synchronized with the maximum of tumors induced by
oncovirus [7, 52, 53, 69, 70].
Comparison of exogenous DNAs, introduced into
the cells by different methods, with MGEs, opened by
Mac-Klintok in 1956, seems to be reasonable. Hesin
considered that practically any nucleotide sequence sur-
rounded with DNA-repeats, might become a mobile
genetic element [3]. Thus it is necessary to consider
that the MGEs of various types can be introduced into
the cellular system with exogenous DNAs while some
MGEs might be activated in cell genome as a result of
transfection or genomic stress [70, 73].
We have shown the induction of gene mutations af-
ter the introduction of human Alu-repeat as a part of the
recombinant plasmid into Chinese hamster cells in vit-
ro [7, 68]. The mutagen activity of Alu-repeat which
does not code for protein products, but is an actively
expressed genetic element, testifies to a possible role of
RNA transcripts in mutagenic process with turning on
the mechanism of reverse transcription and transposi-
tion [9, 71–73].
We undertook bioinformation search which revea-
led the existence of a large number of MGEs of various
classes in human genome (including MGMT gene) [99,
100]. MGEs transpositions, apparently, play an essen-
tial role in processes of normal development, and diffe-
rentiation of stem cells, as well as in malignant transfor-
mation. But a question was posed, why as a response to
introduction of various natural and synthetic polynuc-
leotides into the sexual cells of drosophila, some speci-
fic mutations appeared in certain loci [12, 13]. It was po-
stulated that probably different transpositions of va-
rious MGEs in the corresponding sensitive sites of cel-
lular DNA were induced. In a genome of higher euka-
ryotes where coding sequences are only «islands in the
ocean» (3–5 % of a genome), MGEs integration most
often happens in nucleotide sequences of excess DNA
[9, 17, 18, 70, 101, 102].
In the research of Gazaryan et al. on transgenic mice
with a recombinant plasmid pBR322 containing Raus
sarcoma provirus, the integration of plasmid nucleotide
sequence in a mouse genome [45, 46] was shown in se-
veral cases. However, direct link between an insertion
and a mutation came to light not always. Besides, loss
of viral nucleotide sequences did not lead to a change in
the mutant phenotype. The authors also came to a con-
clusion that the transfection resulted in the induction of
transpositions of cell MGEs which caused locus speci-
fic mutations.
When studying biological mutagenesis in somatic
mammalian cells in vitro the locus specificity was not
revealed. However, the existence of areas on chromo-
somes, in places of concentration of the Alu-repetitions
sensitive to action of different mutagens [9, 72, 73] was
established. The analysis of the data specified that
Alu-elements can act as «hot spots» of recombinational
and mutational events, and also mediators of homolo-
gical and nonhomological recombinations. From this
point of view hprt gene chosen by us for investigations
which incorporates 49 copies of the Alu-element, pla-
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ced in sense- and antisense directions, is a perspective
model locus for mutational researches [103].
Mathematical remodeling of induced mutagenesis
was carried out to allocate the factors determining muta-
genic process in the system «adenovirus–cell» [104,
105]. Summarizing the data, we allocate threemajor fac-
tors of destabilization in the nonpermissive cell system
«oncovirus–cell» (Fig. 1–3). The primary factor of de-
stabilization is the expression of the early regulatory vi-
ral genes responsible for stimulation of DNA replica-
tion and malignant transformation. The secondary fac-
tor of destabilization is reprogramming cellular geno-
me (change in the activity and mutations of cellular ge-
nes and regulatory elements, transpositions of MGEs)
under the influence of the expression of early viral genes
and their integration with cellular DNA. An additional
factor which increases probability of mutations is a ca-
pability of exogenous genetical matrix to interact with
cellularDNA-connecting repair enzymes. The final resul-
tant effect of mutagenesis and malignant transforma-
tion is defined by interaction of viral and cellular genes.
Mutagenesis and reprogramming the cells. In the
course of malignant transformation under the influence
of oncoviruses, the destabilization of a cell genome is
taking place [4–7, 69]. However, in most cases the mu-
tations themselves do not define the end result, and on-
ly provide a genetic variety for selection at the cell po-
pulation level. Presumably, the failures of genetic pro-
gramming or realization of incorrect program of gene
expression under virus influence play main role.
It is possible to assume that a sharp change in the ge-
ne expression program is accompanied by mutational
and recombinational variability as it occurs, for examp-
le, at the formation of antibody producing cells [22].
For example, the induction of genetic damages might be
observed during reprogramming the cells which hap-
pens at the differentiation of stem cells into specialized
tissues under the influence of the corresponding regula-
tory signals, growth factors, cytokines, etc. The study on
signal-regulatory ways in stem cells opens a new page
in research of mutagenesis regulation and in understan-
ding its true role in the development and differentiation
[106]. It has a special value when investigations deal
with populations of stem and progenitor cells which are
intended to be used for cell therapy of human diseases
[107, 108] or for creation of «knock-out» animals when
remodeling human diseases [109]. Therefore the study
on mutagenesis in populations of stem cells in vitro and
in vivo is promoted.
In differentiated cell populations there are condi-
tions for emergence of mistakes in cellular DNA. There
are the errors of epigenetic changes in the standard me-
thylation which are followed by DNA damages [15]
and MGEs tranpositions [9, 17, 18, 72, 73, 98]. This
supposition is supported by the data that stem cells are
more resistant to external mutagens and mutate with
lower frequency in comparison with specialized cells
[110].
Of course, a rejection of the cells, not correspon-
ding to a new program, by apoptosis takes place; how-
ever, some damages are realized into mutations which
might serve as sources of different diseases. Various
chromosomal mutations arising at differentiation of ger-
minal cell lines and realizing into diseases of reproduc-
tive system are considered in details [111].
Mutagenesis and reprogramming are the necessary
components or mechanisms of eukaryotic cell systems.
Thus mutagenesis has to be accepted as a reality and
should be studied for realizing a possibility to control it
[112]. We tried to apply a system biology approachs of
minimization, simplification and mathematical remode-
ling to eukaryotic cell systems in vitro for better under-
standing how to operate mutagenesis with a help of bio-
logical factors, and then to use this knowledge for bet-
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Introduction of viral DNAs into the cells
Substrate interactions of viral DNAs with cell components
Expression of early viral operons
Early mutagenic effect:
1. Integration of viral
DNAs under the control
of cell genes
3. Integration of viral
DNAs under the control
of early areas E1 + E4
2. Integration of viral DNAs under
the control of transforming area E1
Remote mutagenic effect
Tumor transformation
Fig. 3. Sequence of the events in the system «adenovirus–cell» during
reprogramming the mammalian cells to tumor transformation
ter understanding a human organism with all its specific
features.
Considering the spontaneous and induced mutation
process, one can understand that it is necessary to use
pharmaceuticals reasonably because some of them are
mutagenic, and their irrational application leads to
emergence of new forms of pathogens, microorganisms
resistant to any medical preparation [113]. The applica-
tion of antimutagens cannot be a panacea, because their
action depends on many factors: concentrations and ac-
tivities, penetration and metabolic changing under the
influence of internal conditions, interaction with an in-
dividual organism. Nobel laureate James Watson has
made a sensational announcement that too intensive ap-
plication of antioxidants preparations which serve as an-
timutagens might be harmful for people increasing the
risk of cancer and diabetes development.
Certainly, rather simple cellular systems (somatic
mammalian cells in vitro) are created and supported by
the researcher, as the laboratory lines of animals, for
example knock-out mice [109]. Manipulating experi-
mental models the researcher begins to understand bet-
ter the own organism as a device. It is possible to learn,
for example, with a help of virus how to operate with
mutagenesis and reprogramming cellular genome. The
oncovirus is acting as a «managing director» in the cell
during long time, but a cell often gets rid of it or silen-
ces it [71, 46–48, 92–98]. Still, in any case the recove-
ry of a cell comes when virus mission is completed, in-
formation is transferred, and the cell system is changed
or reprogrammed. Operating with the model systems
the researcher realizes that the human genome is also a
set of the computer programs which are a subject for tes-
ting, optimization, and if necessary – reorganization.
At the same time the managing director is only dea-
ling with what is given to him but the all program should
be known only at higher levels of the organization. It
looks like the researcher who has created a cellular mo-
del for studying mutagenesis, acts at a higher level re-
garding this model. The man can become the managing
director of himself as well: an individual after all has
the right to dispose the own organism (i. e. cell popu-
lations, of which he, as a matter of fact, consists). At the
same time everyone should remember that he is only a
small part of the nature which is, a matter of fact, repro-
gramming our development. Otherwise, we evolve to-
gether with viruses and all noosphere would have stop-
ped existence long time ago at quickly changing condi-
tions of the modern world.
However, it seems that our consciousness does not
always keep up in accordance with real life and cer-
tainly influence on health and morbidity [114]. So,
maybe, first of all, it is necessary to raise the level of our
own self-consciousness, at least, to become the mana-
ging director of the own organism.
Ë. Ë. Ëóêàø
Ðåãóëÿö³ÿ ìóòàãåíåçó åêçîãåííèìè á³îëîã³÷íèìè ÷èííèêàìè
â åâêàð³îòíèõ êë³òèííèõ ñèñòåìàõ
Ðåçþìå
Ïðîàíàë³çîâàíî óÿâëåííÿ ùîäî ïðèðîäè ìóòàö³é ³ ñïîíòàííîãî
ìóòàö³éíîãî ïðîöåñó, à òàêîæìóòàãåíåçó, ³íäóêîâàíîãî åêçîãåí-
íèìè îíêîâ³ðóñàìè, ÄÍÊ ³ á³ëêàìè-ì³òîãåíàìè. Åêçîãåíí³ á³îëî-
ã³÷í³ ÷èííèêè ³íäóêóþòü ïîøêîäæåííÿ ÄÍÊ ðåãóëÿòîðíî-³íôîð-
ìàö³éíèì øëÿõîì, ä³þ÷è íà ñèñòåìè ï³äòðèìêè ãåíåòè÷íî¿ ñòà-
á³ëüíîñò³. Ìîëåêóëÿðí³ ìåõàí³çìè ìóòàö³é òàê³ ñàì³, ÿê ³ çà ñïîí-
òàííîãî ìóòàãåíåçó, àëå ðåàë³çóþòüñÿ çà ó÷àñò³ ÷óæîð³äíîãî ãå-
íåòè÷íîãî ìàòåð³àëó. Ñåðåä á³îãåííèõ ìóòàãåí³â âèîêðåìëþþòü
îíêîâ³ðóñè ³ ìîá³ëüí³ ãåíåòè÷í³ åëåìåíòè (ÌÃÅ) ÿê íàéñèëüí³ø³
äåñòàá³ë³çóâàëüí³ ôàêòîðè, ùî êîíòðîëþþòü ïðîöåñ çëîÿê³ñíî¿
òðàíñôîðìàö³¿ ñîìàòè÷íèõ êë³òèí ññàâö³â. Ãåíåòè÷íå ïåðåïðî-
ãðàìóâàííÿ àáî çì³íà ïðîãðàì ãåííî¿ åêñïðåñ³¿ ïðè äèôåðåíö³þ-
âàíí³ ñòîâáóðîâèõ êë³òèí ³ êë³òèí-ïîïåðåäíèê³â ï³ä âïëèâîì ðîñ-
òîâèõ ôàêòîð³â è öèòîê³í³â, éìîâ³ðíî, òàêîæ ñóïðîâîäæóºòüñÿ
ìóòàö³ÿìè é ðåêîìá³íàö³ÿìè.
Êëþ÷îâ³ ñëîâà: ìóòàãåíåç, ìóòàö³ÿ, êë³òèíè åâêàð³îò³â, îíêî-
â³ðóñè, ÌÃÅ, á³ëîê-ì³òîãåí.
Ë. Ë. Ëóêàø
Ðåãóëÿöèÿ ìóòàãåíåçà ýêçîãåííûìè áèîëîãè÷åñêèìè ôàêòîðàìè
â ýóêàðèîòíûõ êëåòî÷íûõ ñèñòåìàõ
Ðåçþìå
Ïðîàíàëèçèðîâàíû ïðåäñòàâëåíèÿ î ìóòàöèÿõ è ïðèðîäå ñïîí-
òàííîãî ìóòàöèîííîãî ïðîöåññà, à òàêæå î ìóòàãåíåçå, èíäóöè-
ðîâàííîì ýêçîãåííûìè îíêîâèðóñàìè, ÄÍÊ è áåëêàìè-ìèòîãåíà-
ìè. Ýêçîãåííûå áèîëîãè÷åñêèå ôàêòîðû èíäóöèðóþò ïîâðåæäå-
íèÿ ÄÍÊ ðåãóëÿòîðíî-èíôîðìàöèîííûì ïóòåì, îêàçûâàÿ âëèÿ-
íèå íà ñèñòåìû ïîääåðæàíèÿ ãåíåòè÷åñêîé ñòàáèëüíîñòè. Ìîëå-
êóëÿðíûå ìåõàíèçìû ìóòàöèé òàêèå æå, êàê è ïðè ñïîíòàííîì
ìóòàãåíåçå, íî ðåàëèçóþòñÿ ïðè ó÷àñòèè ÷óæåðîäíîãî ãåíåòè-
÷åñêîãî ìàòåðèàëà. Ñðåäè áèîãåííûõ ìóòàãåíîâ âûäåëÿþò îíêî-
âèðóñû è ìîáèëüíûå ãåíåòè÷åñêèå ýëåìåíòû (ÌÃÝ) êàê íàèáîëåå
ñèëüíûå äåñòàáèëèçèðóþùèå ôàêòîðû, êîíòðîëèðóþùèå ïðî-
öåññ çëîêà÷åñòâåííîé òðàíñôîðìàöèè ñîìàòè÷åñêèõ êëåòîê ìëå-
êîïèòàþùèõ. Ãåíåòè÷åñêîå ïåðåïðîãðàììèðîâàíèå èëè ñìåíà ïðî-
ãðàìì ãåííîé ýêñïðåññèè ïðè äèôôåðåíöèðîâêå ñòâîëîâûõ êëå-
òîê è êëåòîê-ïðåäøåñòâåííèêîâ ïîä âëèÿíèåì ðîñòîâûõ ôàêòî-
ðîâ è öèòîêèíîâ, ïî-âèäèìîìó, òàêæå ñîïðîâîæäàåòñÿ ìóòàöè-
ÿìè è ðåêîìáèíàöèÿìè.
Êëþ÷åâûå ñëîâà: ìóòàãåíåç, ìóòàöèÿ, êëåòêè ýóêàðèîòîâ,
îíêîâèðóñû, ÌÃÝ, áåëîê-ìèòîãåí.
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